We describe a patient who was admitted to hospital after returning from a holiday in Thailand with coronary artery disease and ventricular tachycardia. As an incidental finding, the routine chest radiography showed migratory pulmonary infiltrates. A peripheral blood smear showed eosinophilia. Physical examination revealed multiple, slightly raised, erythematous, serpentine tracks on the buttocks. A clinical diagnosis of larva migrans was made, and the patient was treated with oral albendazole 400 mg on 5 consecutive days and a single dose of oral praziquantel 3,600 mg. By the end of treatment, most of the cutaneous lesions, the pulmonary infiltrates and the peripheral eosinophilia had resolved. The final diagnosis was larva migrans associated with Löffler’s syndrome.

Keywords:
Larva migrans, Löffler’s syndrome, Peripheral eosinophilia, Albendazole
1.
Caumes E: Treatment of cutaneous larva migrans. Clin Infect Dis 2000;30:811–814.
2.
Guill MA, Odom RB: Larva migrans complicated by Loeffler’s syndrome. Arch Dermatol 1978;114:1525–1526.
3.
Wong-Waldamez A, Silva-Lizama E: Bullous larva migrans accompanied by Loeffler’s syndrome. Int J Dermatol 1995;34:570–571.
4.
Wright DO, Gold EM: Loeffler’s syndrome associated with creeping eruption (cutaneous helminthiasis). JAMA 1945;128:1082–1083.
5.
Le Coulant P, Texier L, Tamisier JM, Geniaux M: Cutaneous larva migrans and Loeffler’s type of pulmonary infiltrate. Ann Dermatol Syphiligr 1969;76:641–642.
6.
Vaylet F, Grassin F, Le Vagueresse R, Piens MA, Guigay J, Marotel C, Natali F, L’Her P: Les poumons éosinophiles parasitaires. Rev Pneumol Clin 1998;54:329–339.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.